The International Working Group on the Diabetic Foot (IWGDF) has unveiled 2023 guidelines which now includes topical oxygen therapy as a positive adjunctive treatment recommendation.

The announcement, which occurred at the International Symposium on the Diabetic Foot (ISDF), puts the therapy in line with positive sentiment by the American Diabetes Association (ADA).

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Oxygen therapy product developers such as AOTI will benefit from the recommendation. AOTI’s therapy uses cyclical pressurised oxygen that can be applied directly to a wound site. Amongst other indications – such as venous leg ulcers, burn wounds and pressure ulcers – diabetic foot ulcers (DFU) are a key chronic wound use of the products. Oxygen promotes faster and more durable healing, whilst compression reduces oedema and enhances vascular circulation.

According to the Oceanside, California-based company, its therapy is different to other topical oxygen techniques in that it “provides a multimodality treatment, combining higher pressure oxygen delivery with non-contact cyclical compression and humidity, applied by the patient at home.” In a study, AOTI therapy was shown to reduce hospitalisations and amputations.

“We are thrilled to see the IWGDF follow the lead of the ADA in recognizing the overwhelming body of clinical evidence now supporting topical oxygen therapy in healing DFUs,” said Dr. Mike Griffiths, CEO and President of AOTI.

Research by GlobalData valued the oxygen therapy devices market at $440m in 2022. Primary factors driving the market are increasing incidences of acute and chronic wounds and increasing numbers of patients living from diabetes. In July 2022, wound care company MolecuLight reported boosted healing in DFUs with use of its autofluorescence imaging device to view bacterial presence.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of the Quantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact